vimarsana.com
Home
Live Updates
Targeted Delivery of IL-12 Shows Preliminary Antitumor Activity in Advanced Solid Tumors : comparemela.com
Targeted Delivery of IL-12 Shows Preliminary Antitumor Activity in Advanced Solid Tumors
A high proportion of patients with metastatic solid tumors experienced stable disease following treatment with the immunocytokine in the DODEKA trial.
Related Keywords
Milano ,
Lombardia ,
Italy ,
Milan ,
Giuseppe Curigliano ,
Pfizer ,
Astrazeneca ,
University Of Milano ,
Anticancer Therapies Congress ,
Novartis ,
Anticancer Therapies ,
Medical Oncology ,
Clinical Division ,
Early Drug Development ,
European Institute ,
Istituto Europeo ,
Exact Sciences ,
Smo Targeted Anticancer Therapies Congress ,
News ,
Conference ,
Solid Tumors ,
comparemela.com © 2020. All Rights Reserved.